Healthcare
Live Price
Offline$141.17
-0.06% today
1Y Change
-15.80%
Window
Jun 23, 2025 → May 29, 2026
Coverage: 236 bars · Jun 23, 2025 → May 29, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Universal Health Services, Inc. (UHS) is a Healthcare stock with a market cap of $10.46B and listed on NYSE. The stock last traded around $141.17 and down 15.8% across the available one-year price window (Jun 23, 2025 → May 29, 2026). Baseline metrics include revenue growth of +9.7%, EPS growth of +36.5%, a dividend yield of 0.5%. What stands out right now is revenue +9.7%, EPS +36.5%, free cash flow -24.4% with operating margin 11.5% and ROIC 11.8%. The dividend is present but secondary, with a yield around 0.5%. Valuation is more restrained than many high-expectation growth names at P/E 6.7 and price/sales 0.6. Stock Foundry combines UHS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
UHS
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
UHS Max Drawdown
-40.16%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for UHS and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$12.6B
-5.7% YoY
FY Net Income
$991.6M
+46.8% YoY
Free Cash Flow
$28.0M
-89.3% YoY
Revenue Growth
+9.7%
EPS Growth
+36.5%
Gross Margin
71.3%
Net Margin
8.6%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 17.4B | 15.8B | 14.3B | 13.4B | 12.6B |
| Gross Profit | 15.7B | 14.2B | 12.7B | 11.9B | 11.2B |
| Operating Income | 2.0B | 1.7B | 1.2B | 1.0B | 1.4B |
| EBITDA | 2.7B | 2.3B | 1.7B | 1.6B | 1.9B |
| Net Income | 1.5B | 1.1B | 718M | 676M | 992M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 138M | 126M | 119M | 103M | 115M |
| Total Assets | 16.0B | 14.5B | 14.0B | 13.5B | 13.1B |
| Total Liabilities | 8.5B | 7.7B | 7.8B | 7.5B | 6.9B |
| Shareholder Equity | 7.3B | 6.7B | 6.1B | 5.9B | 6.1B |
| Total Debt | 5.5B | 5.0B | 5.4B | 5.3B | 4.6B |
| Net Debt | 5.4B | 4.8B | 5.2B | 5.2B | 4.4B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
884M
-11.3% YoY
Capital Expenditures
856M
-16.6% YoY
Free Cash Flow
28M
-89.3% YoY
Key ratios
Gross Margin
71.3%
Operating Margin
11.5%
Net Margin
8.6%
ROE
20.9%
Debt / Equity
0.68x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.